Both KLK4 mRNA and protein levels have been reported to be a prognostic marker in various types of cancer: in prostate, oral and breast cancer, overexpression of KLK4 protein and mRNA was associated with an unfavorable prognosis [29,34–36]. The gene discussed is KLK4; the disease is breast carcinoma.